Skip to content
Recall Observatory FDA recall evidence

Device product

Tosoh ST AIA-PACK HbA1c, HbA1c Reagent, Pt. No. 025218 The device is designed for In Vitro Diagnostic Use Only for the quantitative measurement for percent concentration of Hemoglobin A1c (HbA1c) in EDTA whole blood on Tosoh AIA System Analyzer. HbA1c measurement is used in the management and treatment of diabetes.

Z-1809-2018

March 05, 2018

Class II

Product summary

Firm
Tosoh Bioscience Inc
Event
Event 79708
Status
Terminated
Classification
Class II
Quantity
6049
Official record key
device-enforcement:Z-1809-2018

Official wording

Reason: The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.

Code information: All lots.

Distribution pattern: USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.